Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479723 · ClinicalTrials.gov registry record
Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 1,793
- Enrollment target
NCT03479723: Completed study, sponsored by Massachusetts General Hospital.
NCT03479723 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,793 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03479723 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 1,793 participants
- Enrollment target
Study Summary
The purpose of this study is to perform pooled analysis with data collected from 5 previously published studies and 8 unpublished datasets collected from international sites. The main goal of this study is to identify the predictors of plaque erosion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,793 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2024-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03479723
The ClinicalTrials.gov registry entry for NCT03479723 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,793 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03479723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03479723 about?
NCT03479723 is a clinical study titled "Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome". The purpose of this study is to perform pooled analysis with data collected from 5 previously published studies and 8 unpublished datasets collected from international sites. The main goal of this study is to identify the predictors of plaque erosion.
What is the current status of trial NCT03479723?
This trial is currently completed. The enrollment target is 1,793 participants. The study started on 2017-12-01. Estimated completion is 2024-08-01.
Who is sponsoring clinical trial NCT03479723?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.